US Capitol Capsule: US drug shortages worsen, putting patients increasingly at risk
This article was originally published in Scrip
The ongoing problem in the US of drug shortages, particularly for cancer and anesthesia agents, has only gotten worse in 2011, compared with the record-high numbers reached in 2010, with those figures increasing by nearly 200% since 2005, regulators reported on 9 June. The shortage crisis has resulted in some hospitals rationing medicines, while doctors also reported they have been forced to delay or postpone medical procedures.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.